- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hebei Changshan Biochem Pharma (300255)
Hebei Changshan Biochem Pharma stock price live, this page displays SZ 300255 stock exchange data. View the 300255 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hebei Changshan Biochem Pharma real time stock price chart below.
What Is the Hebei Changshan Biochem Pharma Stock Price Today?
The Hebei Changshan Biochem Pharma stock price today is 49.25.
What Is the Stock Symbol for Hebei Changshan Biochem Pharma?
The stock symbol for Hebei Changshan Biochem Pharma is ""300255.""
What Stock Exchange Does Hebei Changshan Biochem Pharma Trade On?
Hebei Changshan Biochem Pharma is listed and trades on the Shenzhen stock exchange.
Is Hebei Changshan Biochem Pharma a Good Stock to Buy?
Determining whether Hebei Changshan Biochem Pharma—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300255 quote. (ISIN: CNE1000016C2)
What Is the Hebei Changshan Biochem Pharma Stock Price Today?
The Hebei Changshan Biochem Pharma stock price today is 49.25.
What Is the Stock Symbol for Hebei Changshan Biochem Pharma?
The stock symbol for Hebei Changshan Biochem Pharma is ""300255.""
What Stock Exchange Does Hebei Changshan Biochem Pharma Trade On?
Hebei Changshan Biochem Pharma is listed and trades on the Shenzhen stock exchange.
Is Hebei Changshan Biochem Pharma a Good Stock to Buy?
Determining whether Hebei Changshan Biochem Pharma—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 300255 quote. (ISIN: CNE1000016C2)
Shenzhen
Currency in CNY
49.25
-1.56(-3.07%)
Closed·
Fair Value
An estimate of a Hebei Changshan Biochem Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
49.20
51.50
52 wk Range
8.91
60.79
300255 Scorecard
Full Analysis
Significant return over the last week
Earnings results expected in 4 days
1/2
Fair Value
An estimate of a Hebei Changshan Biochem Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
49.2051.50
52 wk Range
8.9160.79
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
300255 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Hebei Changshan Biochem Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Hebei Changshan Biochem Pharma Company Profile
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin sodium API and injection. The company was founded in 2000 and is based in Shijiazhuang, China.
Compare 300255 to Peers and Sector
Metrics to compare | 300255 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300255PeersSector | |
|---|---|---|---|---|
P/E Ratio | −246.0x | −13.2x | −0.6x | |
PEG Ratio | −2.77 | 0.05 | 0.00 | |
Price/Book | 28.9x | 3.2x | 2.6x | |
Price / LTM Sales | 45.5x | 4.3x | 3.3x | |
Upside (Analyst Target) | - | −33.8% | 39.1% | |
Fair Value Upside | Unlock | −11.8% | 4.5% | Unlock |
Earnings
Latest Release
Apr 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
258.70M / --
FAQ
What Stock Exchange Does Hebei Changshan Biochem Pharma Trade On?
Hebei Changshan Biochem Pharma is listed and trades on the Shenzhen Stock Exchange stock exchange.
What Is the Stock Symbol for Hebei Changshan Biochem Pharma?
The stock symbol for Hebei Changshan Biochem Pharma is "300255."
What Is the Hebei Changshan Biochem Pharma Market Cap?
As of today, Hebei Changshan Biochem Pharma market cap is 45.25B.
What Is Hebei Changshan Biochem Pharma's Earnings Per Share (TTM)?
The Hebei Changshan Biochem Pharma EPS (TTM) is -0.20.
When Is the Next Hebei Changshan Biochem Pharma Earnings Date?
Hebei Changshan Biochem Pharma will release its next earnings report on 22 Aug 2025.
From a Technical Analysis Perspective, Is 300255 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Hebei Changshan Biochem Pharma Stock Split?
Hebei Changshan Biochem Pharma has split 3 times.
How Many Employees Does Hebei Changshan Biochem Pharma Have?
Hebei Changshan Biochem Pharma has 1254 employees.
What is the current trading status of Hebei Changshan Biochem Pharma (300255)?
As of 19 Aug 2025, Hebei Changshan Biochem Pharma (300255) is trading at a price of 49.25, with a previous close of 50.81. The stock has fluctuated within a day range of 49.20 to 51.50, while its 52-week range spans from 8.91 to 60.79.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.